New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
07:43 EDTAGIOAgios Pharmaceuticals price target raised to $51 from $38 at Leerink
Leerink raised its price target for Agios Pharmaceuticals shares to $51 saying the Phase I data presentation for the AG-221 in IDH2 mutant hematologic malignancies is coming much sooner than expected. The firm keeps an Outperform rating on the stock.
News For AGIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
09:59 EDTAGIOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:34 EDTAGIOCalithera Biosciences price target raised to $30 from $15 at Citigroup
Subscribe for More Information
05:58 EDTAGIOAgios Pharmaceuticals downgraded to Neutral from Buy at Citigroup
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use